A review of monochromatic excimer light in vitiligo

British Journal of Dermatology

Volumn 167, Issue 3, 2012, Pages 468-478

  Park, K K ^a   Liao, W ^a   Murase, J E ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b Palo Alto Foundation Medical Group   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TOCOPHEROL; CALCINEURIN INHIBITOR; CALCIPOTRIOL; CORTICOSTEROID; PIMECROLIMUS; TACALCITOL; TACROLIMUS; VITAMIN D DERIVATIVE; XENON;

ANTIGEN PRESENTATION; APOPTOSIS; CLINICAL TRIAL (TOPIC); DENDRITIC CELL; ERYTHEMA; EXCIMER LASER; FULL THICKNESS SKIN GRAFT; HUMAN; KERATINOCYTE; MELANOCYTE; PHOTOTHERAPY; PRIORITY JOURNAL; PSORIASIS; PUVA; RANDOMIZED CONTROLLED TRIAL (TOPIC); RELAPSE; REVIEW; SKIN ATROPHY; STRIA; ULTRAVIOLET A RADIATION; ULTRAVIOLET B RADIATION; ULTRAVIOLET RADIATION; VITILIGO;

ADULT; CHILD; COMBINED MODALITY THERAPY; DERMATOLOGIC AGENTS; EPIDEMIOLOGIC METHODS; HUMANS; LASERS, EXCIMER; PATIENT SAFETY; PHOTOTHERAPY; SKIN NEOPLASMS; SKIN TRANSPLANTATION; VITILIGO;

EID: 84865585457     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/j.1365-2133.2012.11008.x     Document Type: Review

References (56)

1. Taïeb A, Picardo M,. Epidemiology, definitions and classification. In: Vitiligo (, Picardo M, Taïeb A, eds). Berlin: Springer-Verlag, 2010; 13-24.
2. Weichenthal M, Schwarz T,. Phototherapy: how does UV work? Photodermatol Photoimmunol Photomed 2005; 21: 260-6. (Pubitemid 41387341)
3. Novak Z, Bonis B, Baltás E, et al. Xenon chloride ultraviolet B laser is more effective in treating psoriasis and in inducing T cell apoptosis than narrow-band ultraviolet B. J Photochem Photobiol, B 2002; 67: 32-8. (Pubitemid 34546477)
4. Ozawa M, Ferenczi K, Kikuchi T, et al. 312-nanometer ultraviolet B light (narrow-band UVB) induces apoptosis of T cells within psoriatic lesions. J Exp Med 1999; 189: 711-18. (Pubitemid 29193372)
5. Noborio R, Kobayashi K, Shintani Y, Morita A,. Comparison of the efficacy of calcipotriol and maxacalcitol in combination with narrow-band ultraviolet B therapy for the treatment of psoriasis vulgaris. Photodermatol Photoimmunol Photomed 2006; 22: 262-4. (Pubitemid 44317160)
6. de With A, Greulich KO,. Wavelength dependence of laser-induced DNA damage in lymphocytes observed by single-cell gel electrophoresis. J Photochem Photobiol, B 1995; 30: 71-6.
7. Cui J, Shen LY, Wang GC,. Role of hair follicles in the repigmentation of vitiligo. J Invest Dermatol 1991; 97: 410-16.
8. Norris DA, Horikawa T, Morelli JG,. Melanocyte destruction and repopulation in vitiligo. Pigment Cell Res 1994; 7: 193-203.
9. Yang YS, Cho HR, Ryou JH, Lee MH,. Clinical study of repigmentation patterns with either narrow-band ultraviolet B (NBUVB) or 308 nm excimer laser treatment in Korean vitiligo patients. Int J Dermatol 2010; 49: 317-23.
10. Nistico SP, Saraceno R, Schipani C, et al. Different applications of monochromatic excimer light in skin diseases. Photomed Laser Surg 2009; 27: 647-54.
11. Baltás E, Nagy P, Bonis B, et al. Repigmentation of localized vitiligo with the xenon chloride laser. Br J Dermatol 2001; 144: 1266-7. (Pubitemid 34204227)
12. Spencer JM, Nossa R, Ajmeri J,. Treatment of vitiligo with the 308-nm excimer laser: a pilot study. J Am Acad Dermatol 2002; 46: 727-31.
13. Baltás E, Csoma Z, Ignacz F, et al. Treatment of vitiligo with the 308-nm xenon chloride excimer laser. Arch Dermatol 2002; 138: 1619-20. (Pubitemid 35453488)
14. Cho S, Zheng Z, Park YK, Roh MR,. The 308-nm excimer laser: a promising device for the treatment of childhood vitiligo. Photodermatol Photoimmunol Photomed 2011; 27: 24-9.
15. Do JE, Shin JY, Kim DY, et al. The effect of 308 nm excimer laser on segmental vitiligo: a retrospective study of 80 patients with segmental vitiligo. Photodermatol Photoimmunol Photomed 2011; 27: 147-51.
16. Mouzakis JA, Liu S, Cohen G,. Rapid response of facial vitiligo to 308 nm excimer laser and topical calcipotriene. J Clin Aesthet Dermatol 2011; 4: 41-4.
17. Oh SH, Kim T, Jee H, et al. Combination treatment of non-segmental vitiligo with a 308-nm xenon chloride excimer laser and topical high-concentration tacalcitol: a prospective, single-blinded, paired, comparative study. J Am Acad Dermatol 2011; 65: 428-30.
18. Le Duff F, Fontas E, Giacchero D, et al. 308-nm excimer lamp vs. 308-nm excimer laser for treating vitiligo: a randomized study. Br J Dermatol 2010; 163: 188-92.
19. Zhang XY, He YL, Dong J, et al. Clinical efficacy of a 308 nm excimer laser in the treatment of vitiligo. Photodermatol Photoimmunol Photomed 2010; 26: 138-42.
20. Al-Otaibi SR, Zadeh VB, Al-Abdulrazzaq AH, et al. Using a 308-nm excimer laser to treat vitiligo in Asians. Acta Dermatovenerol Alp Panonica Adriat 2009; 18: 13-19.
21. Yang HL, Huang XY, Fan JY, Liu ZR,. Combination of 308-nm excimer laser with topical pimecrolimus for the treatment of childhood vitiligo. Pediatr Dermatol 2009; 26: 354-6.
22. Sassi F, Cazzaniga S, Tessari G, et al. Randomized controlled trial comparing the effectiveness of 308-nm excimer laser alone or in combination with topical hydrocortisone 17-butyrate cream in the treatment of vitiligo of the face and neck. Br J Dermatol 2008; 159: 1186-91.
23. Hadi S, Tinio P, Al-Ghaithi K, et al. Treatment of vitiligo using the 308-nm excimer laser. Photomed Laser Surg 2006; 24: 354-7. (Pubitemid 44115218)
24. Hofer A, Hassan AS, Legat FJ, et al. The efficacy of excimer laser (308 nm) for vitiligo at different body sites. J Eur Acad Dermatol Venereol 2006; 20: 558-64.
25. Hong SB, Park HH, Lee MH,. Short-term effects of 308-nm xenon-chloride excimer laser and narrow-band ultraviolet B in the treatment of vitiligo: a comparative study. J Korean Med Sci 2005; 20: 273-8.
26. Choi KH, Park JH, Ro YS,. Treatment of vitiligo with 308-nm xenon-chloride excimer laser: therapeutic efficacy of different initial doses according to treatment areas. J Dermatol 2004; 31: 284-92.
27. Esposito M, Soda R, Costanzo A, Chimenti S,. Treatment of vitiligo with the 308 nm excimer laser. Clin Exp Dermatol 2004; 29: 133-7. (Pubitemid 38367193)
28. Hadi SM, Spencer JM, Lebwohl M,. The use of the 308-nm excimer laser for the treatment of vitiligo. Dermatol Surg 2004; 30: 983-6. (Pubitemid 38890905)
29. Kawalek AZ, Spencer JM, Phelps RG,. Combined excimer laser and topical tacrolimus for the treatment of vitiligo: a pilot study. Dermatol Surg 2004; 30: 130-5. (Pubitemid 38313998)
30. Taneja A, Trehan M, Taylor CR,. 308-nm excimer laser for the treatment of localized vitiligo. Int J Dermatol 2003; 42: 658-62. (Pubitemid 37025225)
31. Ostovari N, Passeron T, Zakaria W, et al. Treatment of vitiligo by 308-nm excimer laser: an evaluation of variables affecting treatment response. Lasers Surg Med 2004; 35: 152-6. (Pubitemid 39150415)
32. Passeron T, Ostovari N, Zakaria W, et al. Topical tacrolimus and the 308-nm excimer laser: a synergistic combination for the treatment of vitiligo. Arch Dermatol 2004; 140: 1065-9. (Pubitemid 39223113)
33. Leone G, Iacovelli P, Paro Vidolin A, Picardo M,. Monochromatic excimer light 308 nm in the treatment of vitiligo: a pilot study. J Eur Acad Dermatol Venereol 2003; 17: 531-7. (Pubitemid 37138890)
34. Gawkrodger DJ, Ormerod AD, Shaw L, et al. Guideline for the diagnosis and management of vitiligo. Br J Dermatol 2008; 159: 1051-76.
35. Goldinger SM, Dummer R, Schmid P, et al. Combination of 308-nm xenon chloride excimer laser and topical calcipotriol in vitiligo. J Eur Acad Dermatol Venereol 2007; 21: 504-8. (Pubitemid 46454904)
36. Tang LY, Fu WW, Xiang LH, et al. Topical tacalcitol and 308-nm monochromatic excimer light: a synergistic combination for the treatment of vitiligo. Photodermatol Photoimmunol Photomed 2006; 22: 310-14.
37. Linthorst Homan MW, Spuls PI, Nieuweboer-Krobotova L, et al. A randomized comparison of excimer laser versus narrow-band ultraviolet B phototherapy after punch grafting in stable vitiligo patients. J Eur Acad Dermatol Venereol 2012; 23: 690-5.
38. Nieuweboer-Krobotova L, Veen JPW,. Excimer Laser and Minigrafting- Combination Therapy for Vitiligo. J Eur Acad Dermatol Venerol 2005; 19(Suppl.2): 257-p.08.140.
39. Al-Mutairi N, Manchanda Y, Al-Doukhi A, Al-Haddad A,. Long-term results of split-skin grafting in combination with excimer laser for stable vitiligo. Dermatol Surg 2010; 36: 499-505.
40. Saraceno R, Nistico SP, Capriotti E, Chimenti S,. Monochromatic excimer light 308 nm in monotherapy and combined with topical khellin 4% in the treatment of vitiligo: a controlled study. Dermatol Ther 2009; 22: 391-4.
41. Chimento SM, Newland M, Ricotti C, et al. A pilot study to determine the safety and efficacy of monochromatic excimer light in the treatment of vitiligo. J Drugs Dermatol 2008; 7: 258-63.
42. Xiang L,. Once-weekly treatment of vitiligo with monochromatic excimer light 308 nm in Chinese patients. J Eur Acad Dermatol Venereol 2008; 22: 899-900. (Pubitemid 351837141)
43. Casacci M, Thomas P, Pacifico A, et al. Comparison between 308-nm monochromatic excimer light and narrowband UVB phototherapy (311-313 nm) in the treatment of vitiligo-a multicentre controlled study. J Eur Acad Dermatol Venereol 2007; 21: 956-63. (Pubitemid 47103727)
44. Nistico SP, Saraceno R, Stefanescu S, Chimenti S,. A 308-nm monochromatic excimer light in the treatment of palmoplantar psoriasis. J Eur Acad Dermatol Venereol 2006; 20: 523-6.
45. Leone G, Tanew A,. UVB total body and targeted phototherapies. In: Vitiligo (, Picardo M, Taïeb A, eds). Berlin: Springer-Verlag, 2010; 353-68.
46. Jo SJ, Kwon HH, Choi MR, Youn JI,. No evidence for increased skin cancer risk in Koreans with skin phototypes III-V treated with narrowband UVB phototherapy. Acta Derm Venereol (Stockh) 2011; 91: 40-3.
47. Hearn RM, Kerr AC, Rahim KF, et al. Incidence of skin cancers in 3867 patients treated with narrow-band ultraviolet B phototherapy. Br J Dermatol 2008; 159: 931-5.
48. Black RJ, Gavin AT,. Photocarcinogenic risk of narrowband ultraviolet B (TL-01) phototherapy: early follow-up data. Br J Dermatol 2006; 154: 566-7. (Pubitemid 43382678)
49. Lim JL, Stern RS,. High levels of ultraviolet B exposure increase the risk of non-melanoma skin cancer in psoralen and ultraviolet A-treated patients. J Invest Dermatol 2005; 124: 505-13. (Pubitemid 40381572)
50. Man I, Crombie IK, Dawe RS, et al. The photocarcinogenic risk of narrowband UVB (TL-01) phototherapy: early follow-up data. Br J Dermatol 2005; 152: 755-7. (Pubitemid 40571310)
51. Weischer M, Blum A, Eberhard F, et al. No evidence for increased skin cancer risk in psoriasis patients treated with broadband or narrowband UVB phototherapy: a first retrospective study. Acta Derm Venereol (Stockh) 2004; 84: 370-4. (Pubitemid 39312270)
52. Larko O, Swanbeck G,. Is UVB treatment of psoriasis safe? A study of extensively UVB-treated psoriasis patients compared with a matched control group. Acta Derm Venereol (Stockh) 1982; 62: 507-12. (Pubitemid 13203760)
53. Pittelkow MR, Perry HO, Muller SA, et al. Skin cancer in patients with psoriasis treated with coal tar. A 25-year follow-up study. Arch Dermatol 1981; 117: 465-8. (Pubitemid 11094562)
54. Murase JE, Lee EE, Koo J,. Effect of ethnicity on the risk of developing nonmelanoma skin cancer following long-term PUVA therapy. Int J Dermatol 2005; 44: 1016-21. (Pubitemid 43046120)
55. Nordlund JJ,. Nonmelanoma skin cancer in vitiligo patients. J Am Acad Dermatol 2009; 61: 1080-1.
56. Lindelof B, Hedblad MA, Sigurgeirsson B,. On the association between vitiligo and malignant melanoma. Acta Derm Venereol (Stockh) 1998; 78: 483-4.